phase readout
saveNCT05352893: Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Subjects With GPP
COMPLETEDupdated 1mo ago
community read0 votes
Sponsor: Vanda Pharmaceuticals. Phase: PHASE3. Conditions: Generalized Pustular Psoriasis
view source ↗
comments(0)
5-min edit window · permanent after that